By David Tuller, DrPH So let's talk about Professor Esther Crawley's SMILE trial, published in September by the journal Archives of Disease in Childhood, one of the BMJ Publishing Group's titles. The study reported that a commercial intervention called the Lightning Process was an effective treatment for children with CFS/ME ...

By David Tuller, DrPH Well, last week was certainly exciting! As I wrote on Wednesday, I was planning to post about Professor Esther Crawley's SMILE trial. However, that plan changed when Sue Paterson, the University of Bristol's director of legal services, e-mailed me what I guess was supposed to be ...

By David Tuller, DrPH Update: About 20 minutes after posting this blog, I received the following communication from Ms. Paterson: Dear Dr Tuller Thank you for your email of 22 November. If by a 'cease and desist' letter you mean a letter threatening legal action if the recipient does not ...

By David Tuller, DrPH Earlier today, I e-mailed the following letter to Sue Paterson, University of Bristol's Director of Legal Services, to clarify whether or not I had been sent a cease and desist letter (to cease and desist what, exactly?). Professor Esther Crawley made this claim at her public ...

By David Tuller, DrPH At noon last Friday, at the University of Exeter's Mood Disorders Centre, Professor Esther Crawley gave a talk called What is new in paediatric CFS/ME research. When I saw a notice about the event the day before, I felt it might be my one chance to ...